Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients

NCT01822171 | Terminated

• 1 other identifier: PSPH-002-Pharm
• Study Type: interventional
• Target: 1
• Locations: 1 country
• Sites: 2

Brief Summary

Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.

Conditions

Heart Failure

Keywords

Heart Failure; Medication Therapy Management

Outcome Measures

Primary Outcomes (1)

• Reduction in hospital readmissions

  The readmission rate for the 50 subjects involved in this study will be compared to an equal number patients retrospectively reviewed from a 2011 patient list and matched for heart failure severity. The primary outcome will based on a comparison of the ratio of patients readmitted to the hospital before the discharge instruction program started and after.

  30 day

Secondary Outcomes (4)

• Patient assessment of home medications knowledge at time of hospital discharge

  3 days

• Patient satisfaction with comprehensive discharge counseling service.

  7 Days

• Number of interventions made at the MTM clinic.

  7 Days.

• Types of interventions made at the MTM clinic.

  7 days

Study Arms (1)

Discharge counseling and MTM follow-up

EXPERIMENTAL

At the time of hospital discharge the subject will receive: * Discharge medication counseling from a pharmacist * Home medication if needed * Approximately 7 days after hospital discharge the subject have a Follow-up visit at Medication Therapy Management clinic.

Other: Discharge medication counseling from a pharmacist; Other: Home medication if needed; Other: Follow-up visit at Medication Therapy Management clinic

Interventions

Discharge medication counseling from a pharmacist OTHER

Patient will be educated about proper dosing instructions, potential side effects, and when to recontact the treating physician office.

Discharge counseling and MTM follow-up

Home medication if needed OTHER

Patient will be provided with medication to take home, when needed.

Discharge counseling and MTM follow-up

Follow-up visit at Medication Therapy Management clinic OTHER

This comprehensive Medication Therapy Management clinic follow-up visit is scheduled for 7 days post hospital discharge. The approximately 1 hour visit is scheduled with a pharmacist to review current drug therapy and make recommendations, if needed, to improve medication utilization.

Discharge counseling and MTM follow-up

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Heart Failure with high risk for readmission.
• Enroll in study prior to hospital discharge.

Sponsors & Collaborators

• Providence Health & Services: lead

Study Sites (2)

Providence Centralia Hospital

Centralia, Washington, 98531, United States

Location

Providence St. Peter Hospital

Olympia, Washington, 98506, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases

Study Officials

• Laura Hoekstra, Pharm.D.

  Providence St. Peter Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 7, 2013
• First Posted: April 2, 2013
• Study Start: January 1, 2013
• Primary Completion: May 1, 2013
• Study Completion: May 1, 2013
• Last Updated: May 22, 2013

Record last verified: 2013-05

Locations

US (2)